UTime Ltd (NASDAQ:WTO) shares have experienced extreme volatility this week, with a dramatic 93% drop on Wednesday following the announcement of a non-disclosure agreement with Bowen Therapeutics Inc. for the acquisition of a laboratory at UMASS Medical School.
UTime Ltd（纳斯达克：WTO）股票本周经历了极高的波动性，周三宣布与Bowen Therapeutics Inc.签署了一项非披露协议，以收购UMASS Medical School的实验室，股价暴跌了93％。
The company says this acquisition is part of UTime's strategy to expand into the global vaccine market, focusing specifically on developing a vaccine for mpox (monkeypox).
该公司表示，这一收购是UTime扩大全球疫苗市场的策略的一部分，重点是开发一种针对猴痘（mpox）的疫苗。
Bowen Therapeutics has been conducting research on the mpox virus and has developed what UTime says is a promising hexavalent recombinant protein vaccine. UTime plans to oversee ongoing clinical trials and future vaccine development with an aim to expedite FDA approval.
Bowen Therapeutics一直在对猴痘病毒进行研究，并研制出UTime称之为有希望的六价重组蛋白疫苗。UTime计划监督正在进行的临床试验和未来的疫苗开发，以加速FDA的批准。
Read Also: Why BioCardia (BCDA) Stock Is Up 95% Today
阅读更多：为什么BioCardia（BCDA）股票今天上涨95％
On Thursday, UTime's stock price rebounded by 48% to 13 cents after the company issued a press release addressing the recent share price volatility. The company assured investors that its operations remain normal, and there has been no fundamental change to its business.
周四，UTime的股价回升了48％，至13美分，此前该公司发布新闻稿，提及最近股价波动情况。该公司向投资者保证其经营状况保持正常，并且其业务没有发生根本性变化。
In the press release, UTime emphasized its commitment to transparency and regulatory compliance, noting that it is conducting an internal investigation to determine if any undisclosed information may have contributed to the stock's volatility.
在新闻稿中，UTime强调其对透明度和监管合规性的承诺，并指出正在进行内部调查，以确定是否有任何未披露的信息可能导致股价波动。
The company meanwhile urged investors to remain cautious and rely only on official communications for accurate information.
与此同时，该公司敦促投资者保持谨慎，只依赖官方通讯获取准确信息。
Read Also: U.S. Stocks Rally, Dow Jones Achieves Record Highs As GDP Outperforms, Nvidia Falls: What's Driving Markets Thursday?
阅读更多：美股大涨，道琼斯创历史新高，GDP表现强劲，英伟达下跌：是什么推动了周四的市场？
Should I Sell My WTO Stock?
我应该卖出我的WTO股票吗？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在决定持有或出售股票时，投资者应考虑他们的投资期限、未实现收益和总回报。
Shares of UTime have decreased by 74.64% in the past year. An investor who bought shares of UTime at the beginning of the year would take a loss of $0.14 per share if they sold it today. The stock has fallen 90.16% over the past month, meaning an investor who bought shares on Jul. 1 would see a capital loss of $0.61.
UTime的股票在过去一年中下跌了74.64%。如果投资者今天卖出，那么在年初购买UTime股票的投资者每股将亏损0.14美元。股票在过去一个月内下跌了90.16%，这意味着在7月1日购买股票的投资者将面临0.61美元的资本损失。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. UTime stock currently has an RSI of 19.17, indicating oversold conditions.
投资者也可以考虑市场动态。相对强弱指数可用于判断股票是超买还是超卖。UTime股票当前的RSI为19.17，表明处于超卖状态。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
如需高级图表和分析工具以及股票数据，请访问Benzinga Pro。免费试用。